These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15333358)

  • 1. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions.
    Ito K; Fujita T; Shimizu A; Koike S; Sasaki K; Matsunaga N; Hibino S; Yuhara M
    AJR Am J Roentgenol; 2004 Sep; 183(3):699-705. PubMed ID: 15333358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis or chronic hepatitis: evaluation of small (Shimizu A; Ito K; Koike S; Fujita T; Shimizu K; Matsunaga N
    Radiology; 2003 Feb; 226(2):550-5. PubMed ID: 12563153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.
    Goshima S; Kanematsu M; Kondo H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2009 Mar; 192(3):686-92. PubMed ID: 19234264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Mizuno N; Kawada H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
    Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
    Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique.
    Hong HS; Kim HS; Kim MJ; De Becker J; Mitchell DG; Kanematsu M
    J Magn Reson Imaging; 2008 Aug; 28(2):396-402. PubMed ID: 18666146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of 3.0T MRI 3D-VIBE dynamic contrast-enhanced in the diagnosis of small hepatocellular carcinomas].
    Wang CS; Duan Q; Xue YJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):905-8. PubMed ID: 19105934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas.
    Yoshioka H; Takahashi N; Yamaguchi M; Lou D; Saida Y; Itai Y
    J Magn Reson Imaging; 2002 Sep; 16(3):259-66. PubMed ID: 12205581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small hypervascular hepatocellular carcinomas: value of diffusion-weighted imaging compared with "washout" appearance on dynamic MRI.
    Kim DJ; Yu JS; Kim JH; Chung JJ; Kim KW
    Br J Radiol; 2012 Oct; 85(1018):e879-86. PubMed ID: 22573299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S; Matsui O; Kamura T; Yamamoto S; Yoneda N; Gabata T; Terayama N; Sanada J
    J Comput Assist Tomogr; 2007; 31(4):557-63. PubMed ID: 17882031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.